1. Abboud M, Fushen Xu, Lavia M, Laver J. Study of early hematopoietic precursors in human cord. Blood Cells. 1992;17:287?95.
2. Ardiet C, Bastian G, Favre R et al. (eds) Guide pratique de pharmacocin�tique clinique en oncologie. Paris: Frison Roche Ed; 1989.
3. Aroch M, Dedenon A, Damais C, Averlant G, Guillosson JJ. Mise en �vidence d'un effet protecteur de l'interleukine-1 vis � vis de la toxicit� h�matologique de l'azidothymidine (AZTT) CR Seances Soc Biol Fil. 1992; 186:206?14.
4. Barberi-Heyob M, Merlin JL, Weber B. Dosage of the anabolites of 5-fluorouracil in patients presenting with advanced breast cancer. Proc Annu Meet Am Assoc Cancer Res. 1993;33:A3187.
5. Bechmann RA, McFall PJ, Sikic BI, Smith SD. Doxorubinin and the alkylating anthracycline 3?-deamino-3?-(3-cyano-4 morpholinyl)doxorubicin: comparative in vitro potency against leukemia and bone marrow cells. J Natl Cancer Inst. 1988;80:361?5.